A team of researchers at the University of Pennsylvania have developed a protein attached to a nanoparticle that "fools" the immune system into allowing it to reach tumors. NewsWorks Tonight Host Dave Heller spoke with head researcher Professor Dennis Discher about how it works, its promise for cancer therapy, and more.
Some features of this website (and others) may not work correctly with Internet Explorer 8 and below. Click below and we'll show you your upgrade options (they're free). -your friends at NewsWorks. Update my browser now